FATE THERAPEUTICS DL-,001 financial statements, including revenue, expenses, profit, and loss

The total revenue of F6T for the last quarter is 2.76 M EUR, and it's 56.33% lower compared to the previous quarter. The net income of Q3 24 is -42.82 M EUR.